Yi-Xian Liu, Bao-Zhu Jia, Xu-Chao Zhang, Fei Hou, Jun-Peng Liu, Wei-Yun Guo, Yuan Meng, Zhen-Lin Xu, Lin Luo
{"title":"Development of an ultrasensitive magnetic bead-based non-competitive chemiluminescent immunoassay for 17β-estradiol in milk","authors":"Yi-Xian Liu, Bao-Zhu Jia, Xu-Chao Zhang, Fei Hou, Jun-Peng Liu, Wei-Yun Guo, Yuan Meng, Zhen-Lin Xu, Lin Luo","doi":"10.1007/s00604-025-07175-0","DOIUrl":null,"url":null,"abstract":"<div><p>Chronic dietary intake of 17β-estradiol (E<sub>2</sub>) poses significant health risks, necessitating rapid and accurate analytical techniques for effective surveillance. This study presents a magnetic particle (MP)-assisted non-competitive chemiluminescent immunoassay (NCLIA) designed for E<sub>2</sub> quantification in milk. The NCLIA employs anti-E<sub>2</sub> monoclonal antibody (mAb)-coated MPs to capture E<sub>2</sub> target molecules, followed by the recognition of acridinium ester (AE)-conjugated anti-E<sub>2</sub>@mAb immunocomplex antibody. Magnetic separation facilitates efficient isolation of immunocomplexes before automated luminescence measurement. This NCLIA demonstrated superior performance, without the need for complex pretreatment of milk samples, significantly simplifying the analysis process. The detection limit was as low as 1.57 pg/mL, and total detection time was 8 min. Additionally, NCLIA’s results were highly consistent with those obtained by liquid chromatography-tandem mass spectrometry (LC–MS/MS), validating their reliability in analyzing real samples. Therefore, this study presents an efficient and reliable tool for the rapid screening and detection of 17β-estradiol in milk, which holds significant value for food safety monitoring.</p><h3>Graphical abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":705,"journal":{"name":"Microchimica Acta","volume":"192 5","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microchimica Acta","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1007/s00604-025-07175-0","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Chronic dietary intake of 17β-estradiol (E2) poses significant health risks, necessitating rapid and accurate analytical techniques for effective surveillance. This study presents a magnetic particle (MP)-assisted non-competitive chemiluminescent immunoassay (NCLIA) designed for E2 quantification in milk. The NCLIA employs anti-E2 monoclonal antibody (mAb)-coated MPs to capture E2 target molecules, followed by the recognition of acridinium ester (AE)-conjugated anti-E2@mAb immunocomplex antibody. Magnetic separation facilitates efficient isolation of immunocomplexes before automated luminescence measurement. This NCLIA demonstrated superior performance, without the need for complex pretreatment of milk samples, significantly simplifying the analysis process. The detection limit was as low as 1.57 pg/mL, and total detection time was 8 min. Additionally, NCLIA’s results were highly consistent with those obtained by liquid chromatography-tandem mass spectrometry (LC–MS/MS), validating their reliability in analyzing real samples. Therefore, this study presents an efficient and reliable tool for the rapid screening and detection of 17β-estradiol in milk, which holds significant value for food safety monitoring.
期刊介绍:
As a peer-reviewed journal for analytical sciences and technologies on the micro- and nanoscale, Microchimica Acta has established itself as a premier forum for truly novel approaches in chemical and biochemical analysis. Coverage includes methods and devices that provide expedient solutions to the most contemporary demands in this area. Examples are point-of-care technologies, wearable (bio)sensors, in-vivo-monitoring, micro/nanomotors and materials based on synthetic biology as well as biomedical imaging and targeting.